Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:121 |
---|---|
Enthalten in: |
The journal of clinical investigation - 121(2011), 12, Seite 4889-4903 |
Beteiligte Personen: |
Sancho-Shimizu, V [VerfasserIn] |
---|
BKL: |
---|
Umfang: |
14 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1884564046 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1884564046 | ||
003 | DE-627 | ||
005 | 20230518024604.0 | ||
007 | tu | ||
008 | 111215s2011 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw111215_1 |
035 | |a (DE-627)OLC1884564046 | ||
035 | |a (DE-599)GBVOLC1884564046 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 610 |
084 | |a 44.60 |2 bkl | ||
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Sancho-Shimizu, V |e verfasserin |4 aut | |
245 | 1 | 0 | |a Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency |
264 | 1 | |c 2011 | |
300 | |a 14 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Pérez De Diego, R |4 oth | |
700 | 1 | |a Lorenzo, L |4 oth | |
700 | 1 | |a Halwani, R |4 oth | |
700 | 1 | |a Alangari, A |4 oth | |
700 | 1 | |a Israelsson, E |4 oth | |
700 | 1 | |a Fabrega, S |4 oth | |
700 | 1 | |a Cardon, A |4 oth | |
700 | 1 | |a Maluenda, J |4 oth | |
700 | 1 | |a Tatematsu, M |4 oth | |
700 | 1 | |a Mahvelati, F |4 oth | |
700 | 1 | |a Herman, M |4 oth | |
700 | 1 | |a Ciancanelli, M |4 oth | |
700 | 1 | |a Guo, Y |4 oth | |
700 | 1 | |a Alsum, Z |4 oth | |
700 | 1 | |a Alkhamis, N |4 oth | |
700 | 1 | |a Al-Makadma, A S |4 oth | |
700 | 1 | |a Ghadiri, A |4 oth | |
700 | 1 | |a Boucherit, S |4 oth | |
700 | 1 | |a Plancoulaine, S |4 oth | |
700 | 1 | |a Picard, C |4 oth | |
700 | 1 | |a Rozenberg, F |4 oth | |
700 | 1 | |a Tardieu, M |4 oth | |
700 | 1 | |a Lebon, P |4 oth | |
700 | 1 | |a Jouanguy, E |4 oth | |
700 | 1 | |a Rezaei, N |4 oth | |
700 | 1 | |a Seya, T |4 oth | |
700 | 1 | |a Matsumoto, M |4 oth | |
700 | 1 | |a Chaussabel, D |4 oth | |
700 | 1 | |a Puel, A |4 oth | |
700 | 1 | |a Zhang, S-Y |4 oth | |
700 | 1 | |a Abel, L |4 oth | |
700 | 1 | |a Al-Muhsen, S |4 oth | |
700 | 1 | |a Casanova, J-L |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The journal of clinical investigation |d Ann Arbor, Mich. : American Society for Clinical Investigation, 1924 |g 121(2011), 12, Seite 4889-4903 |w (DE-627)129078700 |w (DE-600)3067-3 |w (DE-576)01441127X |x 0021-9738 |7 nnns |
773 | 1 | 8 | |g volume:121 |g year:2011 |g number:12 |g pages:4889-4903 |g extent:14 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_55 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_252 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4219 | ||
936 | b | k | |a 44.60 |q AVZ |
936 | b | k | |a 44.00 |q AVZ |
951 | |a AR | ||
952 | |d 121 |j 2011 |e 12 |h 4889-4903 |g 14 |